논문 상세보기

두릅 추출물의 기능성 원료 표준화를 위한 HPLC 분석법 검증 KCI 등재 SCOPUS

HPLC analytical method validation of Aralia elata extract as a functional ingredients

  • 언어KOR
  • URLhttps://db.koreascholar.com/Article/Detail/338458
서비스가 종료되어 열람이 제한될 수 있습니다.
한국식품저장유통학회 (The Korean Society of Food Preservation)
초록

Aralia elata Seemann (AE) has long been used as a folk medicine for the treatment of various diseases including diabetes mellitus, anti-arthritic, and anti-gastric ulcer agent in Korea, Japan, and China. This study was performed to establish a simple and reliable HPLC/UV analytical method for determination of most active anti-hypertensive compound, a 3-O-α-L-rhamnopyranosyl(1→2)-α-L-arabinopyranosyl hederagenin 28-O-β-D-xylopyranosyl(1→6)-β-D-glucopyranosylester (HE) for the standardization of the shoot extract of AE as a health functional food ingredient. The quantitative analytical method of HE was optimized by HPLC analysis using reverse-phase C18 column at 40°C with H2O and acetonitrile (70:30, v/v) as an isocratic mobile phase at a flow rate of 1.0 mL/min and detection wavelength of UV 205 nm. This HPLC/UV analytical method showed good specificity and high linearity in the tested range of 0.03125-2.0mg/ml with excellent coefficient of determination (R2) of 0.9999. The limit of detection and limit of quantification were 12.0 μg/mL and 36.5 μg/mL, respectively. Relative standard deviation (RSD) values of data from intra- and inter-day precision were less than 0.2% and 0.1%, respectively. These results indicate that the established HPLC/UV analytical method is very simple, specific, precise, accurate, and reproducible and thus can be useful for the quantitative analysis of HE as a functional anti-hypertensive compound in AE extract.

저자
  • 안은미(대구한의대학교 바이오산업융합학부) | Eun-Mi Ahn (Department of Foodceutical Science, Daegu Hanny University, Gyeongsan 38578, Korea) Corresponding author
  • 최송암((주)두웰바이오) | Song-Am Choi (Dowellbio Inc., Gyeonggi Venture Incubation Center, Suwon 16229, Korea)
  • 최지영((주)두웰바이오) | Ji-Young Choi (Dowellbio Inc., Gyeonggi Venture Incubation Center, Suwon 16229, Korea)